Bradenton, Florida Clinical Trials

A listing of Bradenton, Florida clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 205 clinical trials
OTO-313 in Subjects With Unilateral Subjective Tinnitus

The purpose of this study is to determine the efficacy of OTO-313 in subjects with unilateral tinnitus and to determine the safety and tolerability of OTO-313 in subjects with unilateral tinnitus.

ear barotrauma
sensorineural hearing loss
acoustic trauma
otitis media
Ear Research Foundation
 (7.1 away) Contact site
  • 19 Jun, 2021
  • +11 other locations
Safety and Efficacy of Nyxol With Pilocarpine Eye Drops in Subjects With Presbyopia

The objectives of this study are: To evaluate the efficacy of Nyxol + Pilocarpine to improve DCNVA in subjects with presbyopia

United States, Florida
 (7.4 away) Contact site
  • 27 Apr, 2021
  • +35 other locations
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis

The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Sclerosing Cholangitis (PSC), and to assess the possible impact on the disease progression of PSC.

Florida Research Institute
 (6.5 away) Contact site
  • 29 May, 2021
  • +13 other locations
An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects

This study is being conducted to evaluate the safety and efficacy of ALZ-801 in Early Alzheimer's disease (AD) subjects with the APOE4/4 genotype. This is a double-blind, randomized trial with one dose of ALZ-801 compared to placebo.

Bradenton Research Center
 (8.8 away) Contact site
  • 15 Jun, 2021
  • +38 other locations
A Study of TNB-585 in Subjects With Metastatic Castrate-Resistant Prostate Carcinoma

This is a phase 1, open-label study evaluating the safety, clinical pharmacology and clinical activity of TNB-585, a PSMA x CD3 T-cell engaging bispecific antibody, in subjects with metastatic castrate-resistant prostate cancer (mCRPC) who have received 2 or more prior lines of therapy. The study consists of 2 parts, a …

Florida Cancer Specialists
 (5.4 away) Contact site
  • 26 May, 2021
  • +2 other locations
Study to Assess the Efficacy Safety and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression Agitation and Irritability in Patients With Traumatic Brain Injury

This is a multicenter, randomized, placebo-controlled study to evaluate AVP-786 for the treatment of neurobehavioral disinhibition including aggression, agitation, and irritability in participants with traumatic brain injury (TBI).

Roskamp Institute Clinic, Inc.
 (3.7 away) Contact site
  • 04 Jun, 2021
  • +83 other locations
Assessment of the GORE EXCLUDER Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms

The purpose of the study is to assess the safety and effectiveness of the GORE EXCLUDER Conformable AAA Endoprosthesis to treat an infrarenal aneurysm located in the abdominal aorta. Performance of the GORE EXCLUDER Conformable AAA Endoprosthesis will be judged by separate performance goals.

aortic aneurysm
Sarasota Vascular Specialists
 (5.4 away) Contact site
  • 15 Jun, 2021
  • +49 other locations
Study of TAS3681 in Metastatic Castration Resistant Prostate Cancer

The purpose of this trial is to investigate the safety and tolerability of TAS3681, to find the maximum tolerated dose (MTD)/recommended dose of TAS3681 (Escalation Phase) and to further evaluate safety and preliminary efficacy of TAS3681 at the MTD/recommended dose (Expansion Phase).

Sarah Cannon Research Institute
 (5.4 away) Contact site
  • 16 May, 2021
  • +10 other locations
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC

The study is a multi-center, un-blinded, randomized control study of subjects with locally advanced pancreatic adenocarcinoma which is unresectable.

Sarasota Memorial Health Care System
 (6.9 away) Contact site
  • 21 Jun, 2021
  • +48 other locations
2-level Cervical Disc Replacement Comparing Prodisc C SK & Vivo to Mobi-C

A multi-center, prospective, randomized, controlled comparison of the prodisc C SK and prodisc C Vivo to the control, a similar, legally marketed total disc replacement device in subjects with symptomatic cervical disc disease (SCDD).

Kennedy-White Orthopaedic Center
 (4.8 away) Contact site
  • 09 May, 2021
  • +26 other locations